• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用一种可能的杀微生物剂柳氮乙酰腙,保护小鼠免受沙眼衣原体阴道感染。

Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide.

机构信息

Department of Pathology and Laboratory Medicine, University of California, Irvine, CA 92697-4800, USA.

出版信息

J Infect Dis. 2011 Nov;204(9):1313-20. doi: 10.1093/infdis/jir552. Epub 2011 Sep 20.

DOI:10.1093/infdis/jir552
PMID:21933873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3182314/
Abstract

The salicylidene acylhydrazide INP0341 inhibits growth of Chlamydia in HeLa cells, has negligible cell toxicity, and does not inhibit the growth of lactobacilli. The antichlamydial activity of INP0341 was retained when tested in vaginal and semen simulants. Vaginal tissue from INP0341-treated mice appeared similar to control sham-treated mice. To determine whether INP0341 can protect mice from a vaginal challenge, C3H/HeJ mice were either sham or INP0341 treated intravaginally pre- and postinoculation with 5 × 10(2) inclusion-forming units (IFUs) of Chlamydia trachomatis serovar D. Vaginal cultures taken over a month-long period showed a significant difference in the number of control mice that were culture positive versus the number in the INP0341-treated group, 100% (25/25) and 31% (8/26), respectively (P < .05). The quantity of IFUs shed and antibody titers to Chlamydia were significantly higher for the control group (P < .05). In summary, INP0341 is a promising compound to be considered for formulation as a vaginal microbicide.

摘要

水杨酰腙 INP0341 抑制 HeLa 细胞中的衣原体生长,细胞毒性可忽略不计,并且不抑制乳杆菌的生长。在阴道和精液模拟物中进行测试时,INP0341 的抗衣原体活性得以保留。经 INP0341 处理的小鼠阴道组织与对照假处理的小鼠相似。为了确定 INP0341 是否可以保护小鼠免受阴道挑战,C3H/HeJ 小鼠在阴道接种 5×10(2)包涵体形成单位(IFU)沙眼衣原体血清型 D 前后经阴道给予 INP0341 假处理或 INP0341 处理。在一个月的时间内进行的阴道培养显示,对照组中培养阳性的小鼠数量与 INP0341 处理组相比有显著差异,分别为 100%(25/25)和 31%(8/26)(P<.05)。对照组中 IFU 的脱落量和针对衣原体的抗体滴度明显更高(P<.05)。总之,INP0341 是一种很有前途的化合物,可考虑作为阴道杀微生物剂进行制剂开发。

相似文献

1
Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide.使用一种可能的杀微生物剂柳氮乙酰腙,保护小鼠免受沙眼衣原体阴道感染。
J Infect Dis. 2011 Nov;204(9):1313-20. doi: 10.1093/infdis/jir552. Epub 2011 Sep 20.
2
Formulation of the microbicide INP0341 for in vivo protection against a vaginal challenge by Chlamydia trachomatis.用于体内保护以抵御沙眼衣原体阴道感染的杀微生物剂INP0341的配方。
PLoS One. 2014 Oct 30;9(10):e110918. doi: 10.1371/journal.pone.0110918. eCollection 2014.
3
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.候选阴道杀菌剂对沙眼衣原体和淋病奈瑟菌有效。
Int J Antimicrob Agents. 2010 Aug;36(2):145-50. doi: 10.1016/j.ijantimicag.2010.03.018. Epub 2010 Jun 1.
4
Intranasal immunization with Chlamydia trachomatis, serovar E, protects from a subsequent vaginal challenge with the homologous serovar.用沙眼衣原体E血清型进行鼻内免疫,可预防随后同源血清型的阴道感染。
Vaccine. 1999 Jul 16;17(22):2901-7. doi: 10.1016/s0264-410x(99)00131-0.
5
Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.用由沙眼衣原体外膜复合物组成的无细胞疫苗进行免疫可诱导对生殖道攻击的保护作用。
Infect Immun. 1997 Aug;65(8):3361-9. doi: 10.1128/iai.65.8.3361-3369.1997.
6
Examination of Chlamydia trachomatis infection in environments mimicking normal and abnormal vaginal pH.在模拟正常和异常阴道pH值的环境中对沙眼衣原体感染进行检测。
Sex Transm Dis. 2002 Sep;29(9):514-9. doi: 10.1097/00007435-200209000-00004.
7
Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion.细菌 III 型分泌系统水杨醛酰腙抑制剂的临床前药代动力学和抗衣原体活性。
J Antibiot (Tokyo). 2012 Aug;65(8):397-404. doi: 10.1038/ja.2012.43. Epub 2012 Jun 6.
8
Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.免疫球蛋白G亚型对沙眼衣原体在阴道内感染小鼠模型中感染性的影响。
Infect Immun. 1997 Jul;65(7):2693-9. doi: 10.1128/iai.65.7.2693-2699.1997.
9
Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model.基于树枝状大分子的(SPL7013)杀微生物剂凝胶制剂在非人灵长类动物模型中的临床前安全性和有效性评估。
Antimicrob Agents Chemother. 2006 May;50(5):1696-700. doi: 10.1128/AAC.50.5.1696-1700.2006.
10
Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (HemG) and Chlamydia trachomatis infectivity.突变体 hemG 介导对水杨酰腙的抗性,表明原卟啉原氧化酶(HemG)与沙眼衣原体感染之间存在新的联系。
J Bacteriol. 2013 Sep;195(18):4221-30. doi: 10.1128/JB.00506-13. Epub 2013 Jul 12.

引用本文的文献

1
Type III Secretion System in Intestinal Pathogens and Metabolic Diseases.肠道病原体与代谢疾病中的 III 型分泌系统。
J Diabetes Res. 2024 Nov 6;2024:4864639. doi: 10.1155/2024/4864639. eCollection 2024.
2
Beyond Antibiotics: What the Future Holds.超越抗生素:未来会怎样。
Antibiotics (Basel). 2024 Sep 25;13(10):919. doi: 10.3390/antibiotics13100919.
3
Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems.通过抑制与毒力相关的 III 型和 IV 型分泌系统来靶向细菌发病机制。
Front Cell Infect Microbiol. 2023 Jan 10;12:1065561. doi: 10.3389/fcimb.2022.1065561. eCollection 2022.
4
Alternative Therapeutic Interventions: Antimicrobial Peptides and Small Molecules to Treat Microbial Keratitis.替代治疗干预措施:用于治疗微生物性角膜炎的抗菌肽和小分子
Front Chem. 2021 Aug 11;9:694998. doi: 10.3389/fchem.2021.694998. eCollection 2021.
5
The Type III Secretion System: An Overview from Top to Bottom.III型分泌系统:从上到下的概述
Microorganisms. 2021 Feb 22;9(2):451. doi: 10.3390/microorganisms9020451.
6
Bacterial virulence mediated by orthogonal post-translational modification.细菌正交翻译后修饰介导的毒力。
Nat Chem Biol. 2020 Oct;16(10):1043-1051. doi: 10.1038/s41589-020-0638-2. Epub 2020 Sep 17.
7
Attenuation of infection by INP0341, a salicylidene acylhydrazide, in a murine model of keratitis.INP0341,一种水杨酰腙类化合物,对小鼠角膜炎模型感染的抑制作用。
Virulence. 2020 Dec;11(1):795-804. doi: 10.1080/21505594.2020.1776979.
8
Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target.作为抗毒力靶点的三型分泌系统注射体的前景与挑战
EcoSal Plus. 2019 Feb;8(2). doi: 10.1128/ecosalplus.ESP-0032-2018.
9
Type III secretion inhibitors for the management of bacterial plant diseases.III 型分泌系统抑制剂在植物细菌性疾病防治中的应用。
Mol Plant Pathol. 2019 Jan;20(1):20-32. doi: 10.1111/mpp.12736. Epub 2018 Oct 19.
10
Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection.III 型分泌效应因子和 III 型分泌抑制剂苯氧乙酰胺对铜绿假单胞菌感染小鼠模型脓肿形成的影响。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01202-17. Print 2017 Nov.

本文引用的文献

1
Prevalence and risk behaviours for Chlamydia trachomatis and Neisseria gonorrhoeae infection among female sex workers in an HIV/AIDS high-risk area.艾滋病毒/艾滋病高风险地区女性性工作者沙眼衣原体和淋病奈瑟菌感染的患病率及风险行为
Int J STD AIDS. 2011 Feb;22(2):80-4. doi: 10.1258/ijsa.2010.010289.
2
The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis.男男性行为人群中淋巴肉芽肿性尿道炎与 HIV 之间的关联:系统评价和荟萃分析。
BMC Infect Dis. 2011 Mar 18;11:70. doi: 10.1186/1471-2334-11-70.
3
Correlates of HIV-1 genital shedding in Tanzanian women.坦桑尼亚妇女体内 HIV-1 生殖器脱落物的相关因素。
PLoS One. 2011 Mar 1;6(3):e17480. doi: 10.1371/journal.pone.0017480.
4
Clinical evaluation of microbicide formulations.杀微生物剂配方的临床评估。
Antiviral Res. 2010 Dec;88 Suppl 1(Suppl 1):S40-6. doi: 10.1016/j.antiviral.2010.09.008.
5
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.候选阴道杀菌剂对沙眼衣原体和淋病奈瑟菌有效。
Int J Antimicrob Agents. 2010 Aug;36(2):145-50. doi: 10.1016/j.ijantimicag.2010.03.018. Epub 2010 Jun 1.
6
Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia.基于统计的水杨醛酰腙类化合物库的靶向设计及革兰氏阴性菌耶尔森氏菌 III 型分泌系统抑制的多元定量构效关系研究
Bioorg Med Chem. 2010 Apr 1;18(7):2686-703. doi: 10.1016/j.bmc.2010.02.022. Epub 2010 Feb 18.
7
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.临床和亚临床再激活的2型单纯疱疹病毒感染以及1型人类免疫缺陷病毒(HIV-1)诱导的免疫抑制对生殖器和血浆中HIV-1水平的作用。
J Infect Dis. 2008 Jul 15;198(2):241-9. doi: 10.1086/589621.
8
Identification of TbpA residues required for transferrin-iron utilization by Neisseria gonorrhoeae.淋病奈瑟菌利用转铁蛋白-铁所需的TbpA残基的鉴定。
Infect Immun. 2008 May;76(5):1960-9. doi: 10.1128/IAI.00020-08. Epub 2008 Mar 17.
9
Sentinel surveillance of sexually transmitted infections/HIV and risk behaviors in vulnerable populations in 5 Central American countries.中美洲5个国家对弱势群体中的性传播感染/艾滋病毒及风险行为进行哨点监测。
J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):101-11.
10
Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.基于抗逆转录病毒药物的杀微生物剂预防HIV-1性传播。
Annu Rev Med. 2008;59:455-71. doi: 10.1146/annurev.med.59.061206.112737.